MarketSnapShot
Get IDIA - the stock trading app for the modern investor
Last Trade of NEIMETH INTERNATIONAL PHARMACEUTICALS PLC (NEIMETH)
| Date/Time | Last Price | Today's Change | Bid (Size) | Ask (Size) | Day's Range | Volume | Trades Value |
|---|---|---|---|---|---|---|---|
| 02-May-2025 14:30:24.000 | ₦2.60 | -0.25 (-8.77%)% | 319,750 | 255,530 | 2.60 - 2.75 | 811,136 | ₦2,250,150.70 |
Top Bids
| Price | Volume |
|---|---|
| ₦2.60 | 269,750 |
| ₦2.59 | 50,000 |
Top Offers
| Price | Volume |
|---|---|
| ₦2.99 | 5,530 |
| ₦3.12 | 250,000 |
Company Profile
Neimeth International pharmaceuticals plc engages in the manufacture and marketing of pharmaceutical, animal health, and general health care products in Nigeria. It offers consumer products, including analgesics, anthemintiasis, anti-stress/multivitamin, antimalarial/protozoal, antiseptic, and pediatric products; ethical products, which include anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, anti-rheumatic, sedative, and sickle cell products; and veterinary products, which include anthelministics, antibiotics, and vitamins. The company offers its products in various forms, such as powders, capsules, syrups, tablets, and creams. It also offers contract manufacturing/analysis services. The company sells its products through distributors. Neimeth International pharmaceuticals plc was founded in 1957 and is headquartered in lkeja, Nigeria. Website: www.neimethplc.com Founded in: 1957
Income Statement
Statement of Comprehensive Income as at
31-Mar-2018
| Name | Amount |
|---|---|
| Revenue | 2,269,004.00 |
| Profit before taxation | 202,479.00 |
| Taxation | 18,444.00 |
| Profit/(loss) after tax | 184,035.00 |
| Transfer to revenue reserve | 184,035.00 |
| Profit attributable to: | |
| Owners of the company | |
| Non-controlling interest | |
| Earnings per 50k share (k) | 11.00 |
| Net assets per 50k share (k) | 57.00 |
Most Recent Financial Statements for NEIMETH INTERNATIONAL PHARMACEUTICALS PLC
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 3 - FINANCIAL STATEMENT FOR 2024
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 2 - FINANCIAL STATEMENT FOR 2024
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 1 - FINANCIAL STATEMENT FOR 2024
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- Q4 UNAUDITED FINANCIAL STATEMENT FOR 2023
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- AUDITED - FINANCIAL STATEMENT FOR 2023
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC- QUARTER 3 - FINANCIAL STATEMENT FOR 2023
NEIMETH PHARM PLC Q2 RESULTS 2013
NEIMETH PHARM HALF YEAR 2013
NEIMETH PLC AUDITED 2013
NEIMETH PLC FIRST QTR DEC 2013
NEIMETH PLC HALF YEAR MARCH 2014
NEIMETH AUDITED SEPT 2014
NEIMETH PHARMECEUTICALS Q1DEC 2014
NEIMETH Q2 MARCH 2015
NEIMETH - NINE MONTHS JUNE 2015
NEIMETH - SEPT 2015 AUDITED
NEIMETH Q1 DEC 2015
NEIMETH PLC Q2 MARCH 2016
NEIMETH - 9 MONTHS JUNE 2016
NEIMETH PLC AUDITED SEP 2016
NEIMETH - Q1 DEC 2016
NEIMETH PLC - Q2 MARCH 2017
NEIMETH PLC-NINE MONTHS JUNE 2017
Neimeth International Pharmaceuticals Plc - Audited Sept. 2017
Neimeth International Pharmaceuticals Plc - Q1 Dec. 2017
Neimeth International Pharmaceuticals Plc - Q2 March 2018
Neimeth Pharmaceuticals - Nine Months June 2018
Neimeth International Pharmaceuticals Plc - Audited Financial Account for the year ended 30 Sept. 2018
Neimeth International Pharaceuticals Plc - Q1 December 2018
Neimeth International Pharmaceuticals Plc - Half Year Unaudited Financial Statements for the Period ended 31 March 2019
Get IDIA - the stock trading app for the modern investor
Solutions by Business
Product Suites
Company
Contacts
- 8th Floor,
- South Atlantic Petroleum Towers,
- 1 Adeola Odeku Street,
- Victoria Island,
- Lagos, Nigeria.
- Email: solutions@infowarelimited.com
Follow Us
 |
 |
 |
 |